Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The 403 error content and the Home link were removed, exposing the standard study details view.
    Difference
    0.5%
    Check dated 2026-09-28T18:14:59.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A revision label was added, and a substantial list of metadata/keyword terms and related notes was removed from the page, reducing searchable terms and auxiliary information without altering the main study details.
    Difference
    17%
    Check dated 2026-09-21T22:07:49.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, reflecting a new version of the ClinicalTrials.gov content without changing the study details.
    Difference
    0.1%
    Check dated 2026-08-31T16:39:27.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, indicating a newer page build. No study content or user-facing functionality changes are indicated.
    Difference
    0.1%
    Check dated 2026-08-17T12:56:30.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The release notes section now shows Revision: v3.6.4, replacing the previous v3.6.3 entry.
    Difference
    0.1%
    Check dated 2026-07-27T06:18:26.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor revision to the page's documentation/metadata.
    Difference
    0.1%
    Check dated 2026-07-05T04:57:59.000Z thumbnail image

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.